AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Iterum Therapeutics plc Director's Dealing 2021

Apr 21, 2021

34796_dirs_2021-04-21_f31cbe67-b0ae-4a64-a5b7-a6e454b59b1b.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Iterum Therapeutics plc (ITRM)
CIK: 0001659323
Period of Report: 2012-03-12

Reporting Person: Hecht Beth (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	365	Direct